retatrutide 32 Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide — UK research peptide

Recent findings demonstrate that antibiotic-induced gut dysbiosis can also reshape dendritic architecture in adult cortical interneurons (Nakhal et al., 2025a) and stellate cells in the medial entorhinal cortex (Mydeen et al., 2025)

The stomach muscles might be impaired because of underlying conditions, nerve damage, surgery, medication side effects, and more

A federal grand jury in Ohio indicted four Chinese pharmaceutical companies and 25 individuals, alleging that they presented themselves as online pharmacies or chemical companies selling legitimate pharmaceuticals, while deliberately supplying U.S

Multiple consumers report being enrolled in subscription services without clear consent